Cargando…
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
A hyperinflammatory syndrome (HIS) may cause a life-threatening acute respiratory distress syndrome (ARDS) in patients with COVID-19 pneumonia. A prospective series of 100 consecutive patients admitted to the Spedali Civili University Hospital in Brescia (Italy) between March 9th and March 20th with...
Ejemplares similares
-
Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience
por: Garrafa, Emirena, et al.
Publicado: (2020) -
Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy
por: Piva, Simone, et al.
Publicado: (2020) -
Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta‐blockers in patients hospitalized for acute heart failure
por: Carubelli, Valentina, et al.
Publicado: (2021) -
Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy
por: Alberici, Federico, et al.
Publicado: (2020) -
Prognostic significance of serum potassium in patients hospitalized for acute heart failure
por: Lombardi, Carlo Mario, et al.
Publicado: (2022)